Colon & Colorectal Cancer Treatment Research
and Sources of Information & Support
The resources I've gathered together on this page are intended to help people with colon cancer and their loved ones to find information, support, and other resources. These resources are meant to complement and not replace any advice or information from a health care professional.
This site is designed to be fully accessible for people with disabilities; please follow this link to change text size, color, or contrast; please follow this link for other accessibility functions for those with visual, mobility, and other disabilities.
There are 4 sections of resources:
PLEASE NOTE: This web site includes 8 other pages of related sets of resources:
- 12 Useful Steps if You're Diagnosed with Cancer
- Psychological Interventions for People With Cancer: Therapy & Self-Help
- Cancer & Exercise: Prevention & Recovery
- New Resources for Breast Cancer: Treatment Research Articles; Links to Sites; Psychological Aspects; Books
- New Resources for Prostate Cancer: Treatment Research Articles; Links to Sites; Psychological Aspects; Books
- New Resources for Lung Cancer: Treatment Research Articles; Links to Sites; Psychological Aspects; Books
- Resources for Caregiving: Books, Articles, Chapters, & Web Sites
- New Resources for End-of-Life Challenges: Finding Hospices; Creating an At-Home Hospice; Nursing Homes; Living Wills; Advance Directives; etc.
ABC of Colorectal Cancer (2nd ed.) by Annie M. Young, Richard Hobbs, & David Kerr. (2011). Wiley-Blackwell.
Colon & Rectal Cancer: From Diagnosis to Treatment (2nd ed.) by Paul Ruggieri & Addison Tolentino. (2011). Addicus Books.
Colorectal Cancer (Oxford Oncology Library) edited by Daniel Swinson & Matthew Seymour. (2012). Oxford University Press.
Colorectal Cancer: Risk, Diagnosis and Treatments edited by Julianne E. Jenkins. (2012). Nova Science.
Colon Cancer by Toney Allman. (2012). Lucent Books.
Johns Hopkins Patient Guide To Colon And Rectal Cancer by Nita Ahuja. (2012). Jones & Bartlett.
Manual of Fast Track Recovery for Colorectal Surgery (Enhanced Recovery) edited by Nader Francis, Robin H. Kennedy, Olle Ljungqvist, & Monty G. Mythen. (2012). Springer.
Baillargeon, Jacques, et al. (2011), 'Effect of mental disorders on diagnosis, treatment, and survival of older adults with colon cancer', Journal of the American Geriatrics Society, 59 (7), 1268-73.
Bains, Manpreet, et al. (2011), 'Return-to-work guidance and support for colorectal cancer patients: A feasibility study', Cancer Nursing, 34 (6), e1-e12.
Beech, Nicola, Arber, Anne, and Faithfull, Sara (2012), 'Restoring a sense of wellness following colorectal cancer: A grounded theory', Journal of Advanced Nursing, 68 (5), 1134-44.
Carmack, Cindy L., et al. (2011), 'Feasibility of an expressive-disclosure group intervention for post-treatment colorectal cancer patients: Results of the Healthy Expressions study', Cancer, 117 (21), 4993-5002.
Dowswell, George, et al. (2011), 'Men’s experience of erectile dysfunction after treatment for colorectal cancer: Qualitative interview study', BMJ: British Medical Journal, 343 (7831), 1-11.
Getrich, Christina M., et al. (2012), 'Expressions of machismo in colorectal cancer screening among New Mexico Hispanic subpopulations', Qualitative Health Research, 22 (4), 546-59.
Grant, Marcia, et al. (2011), 'Gender differences in quality of life among long-term colorectal cancer survivors with ostomies', Oncology Nursing Forum, 38 (5), 587-96.
Grimmett, Chloe, et al. (2011), 'Lifestyle and quality of life in colorectal cancer survivors', Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care & Rehabilitation, 20 (8), 1237-45.
Hagedoorn, Mariët, et al. (2011), 'Relationship satisfaction in couples confronted with colorectal cancer: The interplay of past and current spousal support', Journal of Behavioral Medicine, 34 (4), 288-97.
Hamilton, Natia S., et al. (2011), 'Use of psychosocial support services among male Veterans Affairs colorectal cancer patients', Journal of Psychosocial Oncology, 29 (3), 242-53.
Hart, Stacey L. and Charles, Susan T. (2012), 'Age-Related Patterns in Negative Affect and Appraisals About Colorectal Cancer Over Time', Health Psychology.
Holt, Cheryl L., et al. (2011), 'Religiosity and physical and emotional functioning among African American and White colorectal and lung cancer patients', Journal of Psychosocial Oncology, 29 (4), 372-93.
Hou, Wai Kai and Wan, Jacky Ho Yin (2012), 'Perceived control mediates the prospective impact of relationship quality in the year after colorectal cancer diagnosis', Annals of Behavioral Medicine, 43 (1), 129-38.
Hyphantis, Thomas, et al. (2011), 'Personality variables as predictors of early non-metastatic colorectal cancer patients’ psychological distress and health-related quality of life: A one-year prospective study', Journal of Psychosomatic Research, 70 (5), 411-21.
Ieropoli, S. C., et al. (2011), 'What models of peer support do people with colorectal cancer prefer?', European Journal of Cancer Care, 20 (4), 455-65.
Jonsson, C. A., Stenberg, A., and Frisman, G. H. (2011), 'The lived experience of the early postoperative period after colorectal cancer surgery', European Journal of Cancer Care, 20 (2), 248-56.
Lynch, Brigid M., et al. (2011), 'Television viewing time of colorectal cancer survivors is associated prospectively with quality of life', Cancer Causes & Control, 22 (8), 1111-20.
McCaughan, Eilis, et al. (2011), 'Exploring and comparing the experience and coping behaviour of men and women with colorectal cancer at diagnosis and during surgery', Journal of Advanced Nursing, 67 (7), 1591-600.
Mols, Floortje, et al. (2012), 'The association between type d personality and illness perceptions in colorectal cancer survivors: A study from the population-based profiles registry', Journal of Psychosomatic Research, No Pagination Specified.
Ohlsson-Nevo, Emma, et al. (2012), 'Life is back to normal and yet not—Partners’ and patient’s experiences of life of the first year after colorectal cancer surgery', Journal of Clinical Nursing, 21 (3-4), 555-63.
Pan, Li-Hui, et al. (2011), 'Symptom distress and self-care strategies of colorectal cancer patients with diarrhea up to 3 months after surgery', Cancer Nursing, 34 (1), E1-E9.
Sharpe, Louise, Patel, Deepa, and Clarke, Stephen (2011), 'The relationship between body image disturbance and distress in colorectal cancer patients with and without stomas', Journal of Psychosomatic Research, 70 (5), 395-402.
Siminoff, Laura A., et al. (2011), 'Doctor, what's wrong with me? Factors that delay the diagnosis of colorectal cancer', Patient Education and Counseling, 84 (3), 352-58.
Sjövall, K., et al. (2011), 'Experiences of living with advanced colorectal cancer from two perspectives—Inside and outside', European Journal of Oncology Nursing, 15 (5), 390-97.
Spence, R. R., Heesch, K. C., and Brown, W. J. (2011), 'Colorectal cancer survivors' exercise experiences and preferences: Qualitative findings from an exercise rehabilitation programme immediately after chemotherapy', European Journal of Cancer Care, 20 (2), 257-66.
Taylor, Claire, Richardson, Alison, and Cowley, Sarah (2011), 'Surviving cancer treatment: An investigation of the experience of fear about, and monitoring for, recurrence in patients following treatment for colorectal cancer', European Journal of Oncology Nursing, 15 (3), 243-49.
Abdelwahab, S., et al. (2012), 'Anti-EGFR (cetuximab) combined with irinotecan for treatment of elderly patients with metastatic colorectal cancer', J Cancer Res Clin Oncol, 138 (9), 1487-92.
Andersen, K. F., et al. (2012), 'Impact of third-line treatment with irinotecan plus cetuximab on non-tumor standardized uptake values in patients with metastatic colorectal cancer', Oncol Lett, 4 (1), 131-34.
Arnold, D. and Stein, A. (2012), 'Personalized treatment of colorectal cancer', Onkologie, 35 Suppl 1, 42-8.
Barnes, E. L. and Long, M. D. (2012), 'Colorectal cancer in women: hormone replacement therapy and chemoprevention', Climacteric, 15 (3), 250-5.
Barton, M. K. (2012), 'Oxaliplatin in the adjuvant treatment of colon cancer', CA Cancer J Clin, 62 (1), 3-4.
Benavides, M., et al. (2012), 'Oxaliplatin in Combination With Infusional 5-Fluorouracil as First-Line Chemotherapy for Elderly Patients With Metastatic Colorectal Cancer: A Phase II Study of the Spanish Cooperative Group for the Treatment of Digestive Tumors', Clin Colorectal Cancer.
Berretta, M., et al. (2012), 'Oxaliplatin-based chemotherapy in the treatment of elderly patients with metastatic colorectal cancer (CRC)', Arch Gerontol Geriatr, 55 (2), 271-5.
Bokemeyer, C., et al. (2012), 'Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: pooled analysis of the CRYSTAL and OPUS randomised clinical trials', Eur J Cancer, 48 (10), 1466-75.
Brunner, N. and Nielsen, H. J. (2012), 'Directions for further improvements of treatment of metastatic colorectal cancer', Scand J Gastroenterol, 47 (3), 363-4.
Cabebe, E. C., Fisher, G. A., and Sikic, B. I. (2012), 'A phase I trial of vandetanib combined with capecitabine, oxaliplatin and bevacizumab for the first-line treatment of metastatic colorectal cancer', Invest New Drugs, 30 (3), 1082-7.
Cavalli-Bjorkman, N., et al. (2012), 'Lower treatment intensity and poorer survival in metastatic colorectal cancer patients who live alone', Br J Cancer, 107 (1), 189-94.
Chia, W. K., Ali, R., and Toh, H. C. (2012), 'Aspirin as adjuvant therapy for colorectal cancer-reinterpreting paradigms', Nat Rev Clin Oncol.
Cirocchi, R., et al. (2012), 'Radiofrequency ablation in the treatment of liver metastases from colorectal cancer', Cochrane Database Syst Rev, 6, CD006317.
Cockbain, A. J., Toogood, G. J., and Hull, M. A. (2012), 'Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer', Gut, 61 (1), 135-49.
Cosimelli, M., et al. (2012), 'Integration of radioembolisation into multimodal treatment of liver-dominant metastatic colorectal cancer', Expert Opin Ther Targets, 16 Suppl 2, S11-6.
Cubero, D. I., et al. (2012), 'Tegafur-uracil is a safe alternative for the treatment of colorectal cancer in patients with partial dihydropyrimidine dehydrogenase deficiency: a proof of principle', Ther Adv Med Oncol, 4 (4), 167-72.
Custodio, A. and Feliu, J. (2012), 'Prognostic and predictive biomarkers for epidermal growth factor receptor-targeted therapy in colorectal cancer: Beyond KRAS mutations', Crit Rev Oncol Hematol.
De Magistris, L., et al. (2012), 'Transjugular Intrahepatic Portosystemic Shunt and Laparoscopic Colorectal Resection: the ideal minimally-invasive management for the treatment of colorectal cancer in severe cirrhotic patients. A case report and literature review', Minerva Chir, 67 (2), 197-201.
Deva, S. and Jameson, M. (2012), 'Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer', Cochrane Database Syst Rev, 8, CD007814.
Di Valentin, T., et al. (2012), 'Eastern Canadian Colorectal Cancer Consensus Conference: application of new modalities of staging and treatment of gastrointestinal cancers', Curr Oncol, 19 (3), 169-74.
Diaz-Rubio, E., et al. (2012), 'First-line XELOX plus bevacizumab followed by XELOX plus bevacizumab or single-agent bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: the phase III MACRO TTD study', Oncologist, 17 (1), 15-25.
Dotan, E., et al. (2012), 'A Phase II Study of Capecitabine, Oxaliplatin, and Cetuximab with or Without Bevacizumab as Frontline Therapy for Metastatic Colorectal Cancer. A Fox Chase Extramural Research Study', J Gastrointest Cancer.
Eberhard, J., et al. (2012), 'A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer', Br J Cancer, 106 (5), 931-8.
Edwards, M. S., et al. (2012), 'A systematic review of treatment guidelines for metastatic colorectal cancer', Colorectal Dis, 14 (2), e31-47.
Engels, B., et al. (2012), 'Phase II study of helical tomotherapy in the multidisciplinary treatment of oligometastatic colorectal cancer', Radiat Oncol, 7, 34.
Engstrom, P. F. (2012), 'Ten years of progress in colon cancer therapy', J Natl Compr Canc Netw, 10 (5), 574-6.
Etienne-Grimaldi, M. C., et al. (2012), 'Multifactorial pharmacogenetic analysis in colorectal cancer patients receiving 5-fluorouracil-based therapy together with cetuximab-irinotecan', Br J Clin Pharmacol, 73 (5), 776-85.
Fiorentini, G., et al. (2012), 'Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study', Anticancer Res, 32 (4), 1387-95.
Franko, J., et al. (2012), 'Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841', J Clin Oncol, 30 (3), 263-7.
Garrido-Laguna, I., et al. (2012), 'KRASness and PIK3CAness in patients with advanced colorectal cancer: outcome after treatment with early-phase trials with targeted pathway inhibitors', PLoS One, 7 (5), e38033.
Glimelius, B. and Cavalli-Bjorkman, N. (2012), 'Metastatic colorectal cancer: current treatment and future options for improved survival. Medical approach--present status', Scand J Gastroenterol, 47 (3), 296-314.
Graham, J. S. and Cassidy, J. (2012), 'Adjuvant therapy in colon cancer', Expert Rev Anticancer Ther, 12 (1), 99-109.
Guerrieri, M., et al. (2012), 'Laparoscopic colectomy is a reliable option for colon cancer treatment', Ann Ital Chir, 83 (3), 239-44.
Gulec, S. A., et al. (2012), 'Yttrium-90 Microsphere-selective Internal Radiation Therapy With Chemotherapy (Chemo-SIRT) for Colorectal Cancer Liver Metastases: An In Vivo Double-Arm-Controlled Phase II Trial', Am J Clin Oncol.
Hainsworth, J. D., et al. (2012), 'A retrospective study of treatment outcomes in patients with carcinoma of unknown primary site and a colorectal cancer molecular profile', Clin Colorectal Cancer, 11 (2), 112-8.
Halama, N., et al. (2012), 'The local immunological microenvironment in colorectal cancer as a prognostic factor for treatment decisions in the clinic: The way ahead', Oncoimmunology, 1 (1), 62-66.
Haney, C. R., et al. (2012), 'Monitoring Anti-Angiogenic Therapy in Colorectal Cancer Murine Model using Dynamic Contrast-Enhanced MRI - Comparing Pixel-by-Pixel with Region of Interest Analysis', Technol Cancer Res Treat.
Hanna, M. G., Jr. (2012), 'Immunotherapy with autologous tumor cell vaccines for treatment of occult disease in early stage colon cancer', Hum Vaccin Immunother, 8 (8).
He, K., et al. (2012), 'Anti-angiogenic therapy for colorectal cancer: on the way to getting better!', Hepatogastroenterology, 59 (116), 1113-7.
Hompes, D., et al. (2012), 'The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study', Ann Surg Oncol, 19 (7), 2186-94.
Hong, Y. S., et al. (2012), 'Randomized Phase II Study of Capecitabine With or Without Oxaliplatin As First-line Treatment for Elderly or Fragile Patients With Metastatic Colorectal Cancer: A Prospective, Multicenter Trial of the Korean Cancer Study Group CO06-01', Am J Clin Oncol.
Hurwitz, H., et al. (2012), 'A Randomized, Phase II Trial of Standard Triweekly Compared with Dose-Dense Biweekly Capecitabine Plus Oxaliplatin Plus Bevacizumab as First-Line Treatment for Metastatic Colorectal Cancer: XELOX-A-DVS (Dense Versus Standard)', Oncologist, 17 (7), 937-46.
Inoue, Y., et al. (2012), 'Optimal use of current chemotherapy in multimodality therapy for advanced colorectal cancer', Oncol Lett, 3 (2), 363-68.
Jehn, C. F., et al. (2012), 'Cetuximab-based therapy in elderly comorbid patients with metastatic colorectal cancer', Br J Cancer, 106 (2), 274-8.
Kesikli, S. A., Unluturk, U., and Kilickap, S. (2012), 'Insulin therapy and cancer-specific mortality in patients with colorectal cancer and diabetes', J Clin Oncol, 30 (14), 1729-30; author reply 30-2.
Kidwell, K. M., et al. (2012), 'Long-term neurotoxicity effects of oxaliplatin added to fluorouracil and leucovorin as adjuvant therapy for colon cancer: Results from National Surgical Adjuvant Breast and Bowel Project trials C-07 and LTS-01', Cancer.
Kim, S. K., et al. (2012), 'Multivariate Analysis of the Survival Rate for Treatment Modalities in Incurable Stage IV Colorectal Cancer', J Korean Soc Coloproctol, 28 (1), 35-41.
Kimura, T., et al. (2012), 'Clinical benefit of high-sensitivity KRAS mutation testing in metastatic colorectal cancer treated with anti-EGFR antibody therapy', Oncology, 82 (5), 298-304.
Klaver, Y. L., et al. (2012), 'Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy', Eur J Surg Oncol, 38 (7), 617-23.
Kmietowicz, Z. (2012), 'Study finds possible role for aspirin as treatment for colon cancer', BMJ, 344, e2988.
Kohne, C. H., et al. (2012), 'First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer', J Cancer Res Clin Oncol, 138 (1), 65-72.
Kress, M. A., et al. (2012), 'Stereotactic body radiation therapy for liver metastases from colorectal cancer: analysis of safety, feasibility, and early outcomes', Front Oncol, 2, 8.
Kruschewski, M., et al. (2012), 'Locally recurrent colorectal cancer: results of surgical therapy', Langenbecks Arch Surg.
Ku, G. Y., Haaland, B. A., and de Lima Lopes, G., Jr. (2012), 'Cetuximab in the first-line treatment of K-ras wild-type metastatic colorectal cancer: the choice and schedule of fluoropyrimidine matters', Cancer Chemother Pharmacol, 70 (2), 231-8.
Kwan, B. Y., et al. (2012), 'Retrospective Review of Efficacy of Radiofrequency Ablation for Treatment of Colorectal Cancer Liver Metastases From a Canadian Perspective', Can Assoc Radiol J.
Lee, H. J., et al. (2012), 'In vitro induction of anterior gradient-2-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses as a potential therapy for colorectal cancer', Exp Mol Med, 44 (1), 60-7.
Lee, W. S., et al. (2012), 'The outcome after stent placement or surgery as the initial treatment for obstructive primary tumor in patients with stage IV colon cancer', Am J Surg, 203 (6), 715-9.
Levine, R. A., et al. (2012), 'Multidisciplinary management of colorectal cancer enhances access to multimodal therapy and compliance with National Comprehensive Cancer Network (NCCN) guidelines', Int J Colorectal Dis.
Li, G. Z., et al. (2012), 'Impact of simultaneous diaphragm resection during hepatectomy for treatment of metastatic colorectal cancer', J Gastrointest Surg, 16 (8), 1508-15.
Liljestrand, P., Harris, J., and Somkin, C. (2012), 'CC4-05: Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer', Clin Med Res, 10 (3), 159.
Limburg, P. J., et al. (2012), 'Postmenopausal hormone therapy and colorectal cancer risk in relation to somatic KRAS mutation status among older women', Cancer Epidemiol Biomarkers Prev, 21 (4), 681-4.
Limsui, D., et al. (2012), 'Postmenopausal hormone therapy and colorectal cancer risk by molecularly defined subtypes among older women', Gut, 61 (9), 1299-305.
Lin, J. H., et al. (2012), 'Postmenopausal hormone therapy is associated with a reduced risk of colorectal cancer lacking CDKN1A expression', Cancer Res, 72 (12), 3020-8.
Lin, K. J., et al. (2012), 'The effect of estrogen vs. combined estrogen-progestogen therapy on the risk of colorectal cancer', Int J Cancer, 130 (2), 419-30.
Loof, J., et al. (2012), 'Effects of DeltaNp73beta on cisplatin treatment in colon cancer cells', Mol Carcinog, 51 (8), 628-35.
Lopez-Gomez, M., et al. (2012), 'Management of colorectal cancer patients after resection of liver metastases: can we offer a tailored treatment?', Clin Transl Oncol.
Lopez-Gomez, M., Merino, M., and Casado, E. (2012), 'Long-term treatment of metastatic colorectal cancer with panitumumab', Clin Med Insights Oncol, 6, 125-35.
Loupakis, F., et al. (2012), 'Clinical impact of anti-epidermal growth factor receptor monoclonal antibodies in first-line treatment of metastatic colorectal cancer: meta-analytical estimation and implications for therapeutic strategies', Cancer, 118 (6), 1523-32.
Madajewicz, S., et al. (2012), 'Multicenter, randomized phase II trial of bevacizumab plus folinic acid, fluorouracil, gemcitabine (FFG) versus bevacizumab plus folinic acid, fluorouracil, oxaliplatin (FOLFOX4) as first-line therapy for patients with advanced colorectal cancer', Invest New Drugs, 30 (2), 772-8.
Makela, J. T. and Kiviniemi, H. (2012), 'Surgical treatment of colorectal cancer in patients aged over 80 years', Int J Colorectal Dis, 27 (8), 1055-60.
Martin, L. K., et al. (2012), 'Yttrium-90 Radioembolization as Salvage Therapy for Colorectal Cancer With Liver Metastases', Clin Colorectal Cancer.
Matsuda, T., et al. (2012), 'Secondary prevention of colorectal cancer -The roles of endoscopy for early detection and treatment', Nihon Shokakibyo Gakkai Zasshi, 109 (7), 1156-65.
Mayer, R. J. (2012), 'Oxaliplatin As Part of Adjuvant Therapy for Colon Cancer: More Complicated Than Once Thought', J Clin Oncol.
Meyerhardt, J. A., et al. (2012), 'Phase I study of cetuximab, irinotecan, and vandetanib (ZD6474) as therapy for patients with previously treated metastastic colorectal cancer', PLoS One, 7 (6), e38231.
Michielsen, A. J., et al. (2012), 'Inhibition of Dendritic Cell Maturation by the Tumor Microenvironment Correlates with the Survival of Colorectal Cancer Patients following Bevacizumab Treatment', Mol Cancer Ther, 11 (8), 1829-37.
Misale, S., et al. (2012), 'Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer', Nature, 486 (7404), 532-6.
Mishima, H., et al. (2012), 'FOLFIRI plus bevacizumab 5 mg/kg versus 10 mg/kg as second-line therapy in patients with metastatic colorectal cancer who have failed first-line bevacizumab plus oxaliplatin-based therapy: a randomized phase III study (EAGLE Study)', Jpn J Clin Oncol, 42 (2), 134-8.
Mochizuki, I., et al. (2012), 'Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trial', Br J Cancer, 106 (7), 1268-73.
Modest, D. P., et al. (2012), 'The influence of KRAS and BRAF mutations on the efficacy of cetuximab-based first-line therapy of metastatic colorectal cancer: an analysis of the AIO KRK-0104-trial', Int J Cancer, 131 (4), 980-6.
Modest, D. P., et al. (2012), 'Cetuximab-based or bevacizumab-based first-line treatment in patients with KRAS p.G13D-mutated metastatic colorectal cancer: a pooled analysis', Anticancer Drugs, 23 (6), 666-73.
Munireddy, S., et al. (2012), 'Thermal tumor ablation therapy for colorectal cancer hepatic metastasis', J Gastrointest Oncol, 3 (1), 69-77.
Muss, H. B. and Bynum, D. L. (2012), 'Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An Underused Lifesaving Treatment', J Clin Oncol, 30 (21), 2576-8.
Neuman, H. B., et al. (2012), 'Surgical treatment of colon cancer in patients aged 80 years and older : Analysis of 31,574 patients in the SEER-Medicare database', Cancer.
Okuno, K., et al. (2012), 'Recent advances in active specific cancer vaccine treatment for colorectal cancer', Curr Pharm Biotechnol, 13 (8), 1439-45.
Pandey, J. P. (2012), 'Mechanism of resistance to cetuximab therapy in colorectal cancer: Possible role of antibodies to immunoglobulin allotypes', MAbs, 4 (5).
Papa, A., et al. (2012), 'Emerging role of cetuximab in the treatment of colorectal cancer', Recent Pat Anticancer Drug Discov, 7 (2), 233-47.
Park, L. C., et al. (2012), 'Bevacizumab as a second- or later-line of treatment for metastatic colorectal cancer', World J Gastroenterol, 18 (10), 1104-9.
Peeters, M. and Price, T. (2012), 'Biologic therapies in the metastatic colorectal cancer treatment continuum--applying current evidence to clinical practice', Cancer Treat Rev, 38 (5), 397-406.
Petrelli, F., Cabiddu, M., and Barni, S. (2012), '5-Fluorouracil or capecitabine in the treatment of advanced colorectal cancer: a pooled-analysis of randomized trials', Med Oncol, 29 (2), 1020-9.
Popa, C., et al. (2012), 'Evaluating the treatment of metastatic colorectal cancer with monoclonal antibodies', J Med Life, 5 (2), 168-72.
Powell, A. G., Edwards, J., and Horgan, P. G. (2012), 'A move towards individualization of patient treatment regimens in colorectal cancer', Colorectal Dis, 14 (2), 255-6.
Quan, D., et al. (2012), 'The role of liver resection for colorectal cancer metastases in an era of multimodality treatment: a systematic review', Surgery, 151 (6), 860-70.
Ragusa, M., et al. (2012), 'Specific alterations of the microRNA transcriptome and global network structure in colorectal cancer after treatment with MAPK/ERK inhibitors', J Mol Med (Berl).
Raouf, S., et al. (2012), 'Use of bevacizumab in the treatment of metastatic colorectal cancer', Br J Hosp Med (Lond), 73 (1), 25-30.
Reddy, S. K., et al. (2012), 'Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases?', J Surg Oncol, 105 (1), 55-9.
Reeves, M. E. (2012), 'Surgical treatment of colorectal cancer hepatic metastasis', J Gastrointest Oncol, 3 (1), 1-2.
Rinaldi, F., George, E., and Adler, A. I. (2012), 'NICE guidance on cetuximab, bevacizumab, and panitumumab for treatment of metastatic colorectal cancer after first-line chemotherapy', Lancet Oncol, 13 (3), 233-4.
Rinella, E. S., Bankaitis, E. D., and Threadgill, D. W. (2012), 'Dietary calcium supplementation enhances efficacy but also toxicity of EGFR inhibitor therapy for colon cancer', Cancer Biol Ther, 13 (3), 130-7.
Scartozzi, M., et al. (2012), 'Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients', Dig Liver Dis, 44 (1), 74-9.
Short, S. S., et al. (2012), 'Adjuvant treatment of early colon cancer with micrometastases: Results of a national survey', J Surg Oncol, 106 (2), 119-22.
Souglakos, J., et al. (2012), 'Randomised phase-II trial of CAPIRI (capecitabine, irinotecan) plus bevacizumab vs FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) plus bevacizumab as first-line treatment of patients with unresectable/metastatic colorectal cancer (mCRC)', Br J Cancer, 106 (3), 453-9.
Stein, A., et al. (2012), 'Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literature', BMC Cancer, 12 (1), 356.
Stein, U., et al. (2012), 'Impact of mutant beta-catenin on ABCB1 expression and therapy response in colon cancer cells', Br J Cancer, 106 (8), 1395-405.
Stintzing, S., et al. (2012), 'FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer-subgroup analysis of patients with KRAS: mutated tumours in the randomised German AIO study KRK-0306', Ann Oncol, 23 (7), 1693-9.
Strickler, J. H. and Hurwitz, H. I. (2012), 'Maintenance therapy for first-line metastatic colorectal cancer: activity and sustainability', Oncologist, 17 (1), 9-10.
--- (2012), 'Bevacizumab-based therapies in the first-line treatment of metastatic colorectal cancer', Oncologist, 17 (4), 513-24.
Sugihara, K., et al. (2012), 'Safety analysis of FOLFOX4 treatment in colorectal cancer patients: a comparison between two Asian studies and four Western studies', Clin Colorectal Cancer, 11 (2), 127-37.
Takara, K., et al. (2012), 'Treatment schedule-dependent effect of 5-fluorouracil and platinum derivatives in colorectal cancer cells', Eur J Pharm Sci, 45 (3), 272-81.
Tsavaris, N., et al. (2012), 'Combined treatment with bevacizumab and standard chemotherapy restores abnormal immune parameters in advanced colorectal cancer patients', Invest New Drugs, 30 (1), 395-402.
Tsutsumi, S., et al. (2012), 'Phase II Trial of Chemotherapy plus Bevacizumab as Second-Line Therapy for Patients with Metastatic Colorectal Cancer That Progressed on Bevacizumab with Chemotherapy: The Gunma Clinical Oncology Group (GCOG) trial 001 SILK Study', Oncology, 83 (3), 151-57.
Tveit, K. M., et al. (2012), 'Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study', J Clin Oncol, 30 (15), 1755-62.
Twelves, C., et al. (2012), 'Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy', Ann Oncol, 23 (5), 1190-7.
Vale, C. L., et al. (2012), 'Does anti-EGFR therapy improve outcome in advanced colorectal cancer? A systematic review and meta-analysis', Cancer Treat Rev, 38 (6), 618-25.
van der Pool, A. E., et al. (2012), 'Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population-based series', Colorectal Dis, 14 (1), 56-61.
Venderbosch, S., et al. (2012), 'Outcome of first line systemic treatment in elderly compared to younger patients with metastatic colorectal cancer: A retrospective analysis of the CAIRO and CAIRO2 studies of the Dutch Colorectal Cancer Group (DCCG)', Acta Oncol.
Wang, T. F. and Lockhart, A. C. (2012), 'Aflibercept in the treatment of metastatic colorectal cancer', Clin Med Insights Oncol, 6, 19-30.
Watanabe, T., et al. (2012), 'Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer', Int J Clin Oncol, 17 (1), 1-29.
Wolff, R. A., et al. (2012), 'A double-blind, randomized, placebo-controlled, phase 2 study of maintenance enzastaurin with 5-fluorouracil/leucovorin plus bevacizumab after first-line therapy for metastatic colorectal cancer', Cancer, 118 (17), 4132-8.
Yamada, Y., et al. (2012), 'Phase II study of oral S-1 with irinotecan and bevacizumab (SIRB) as first-line therapy for patients with metastatic colorectal cancer', Invest New Drugs, 30 (4), 1690-6.
Yoshino, T., et al. (2012), 'Phase I study of sunitinib plus modified FOLFOX6 in Japanese patients with treatment-naive colorectal cancer', Anticancer Res, 32 (3), 973-9.
Zhao, Z., et al. (2012), 'Patterns of treatment with chemotherapy and monoclonal antibodies for metastatic colorectal cancer in Western Europe', Curr Med Res Opin, 28 (2), 221-9.